
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 22, 2021, titled "Glenmark and Bausch Health join together to commercialize RYALTRIS nasal spray in Canada".
Filed with NSE ·

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 22, 2021, titled "Glenmark and Bausch Health join together to commercialize RYALTRIS nasal spray in Canada".
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals